Loading...
Kairali Exports — Arishta Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #11 for Arishta · $14.5K export value · DGFT Verified
Kairali Exports is the #11 Indian exporter of Arishta with $14.5K in export value and 73 verified shipments. Kairali Exports holds a 1.0% market share in Arishta exports across 2 countries. The company exports 3 pharmaceutical products worth $104.7K across 1 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| NEPAL | $632.7K | 340 | 45.0% |
| UNITED ARAB EMIRATES | $267.7K | 1,371 | 19.0% |
| GERMANY | $196.6K | 44 | 14.0% |
| OMAN | $51.8K | 83 | 3.7% |
| UNITED STATES | $47.4K | 164 | 3.4% |
| CANADA | $31.6K | 71 | 2.2% |
| BAHRAIN | $31.1K | 109 | 2.2% |
| MALAYSIA | $27.6K | 204 | 2.0% |
| SINGAPORE | $26.0K | 282 | 1.8% |
| SAUDI ARABIA | $24.5K | 14 | 1.7% |
India exports Arishta to 47 countries. The top destination is NEPAL (45.0%), followed by UNITED ARAB EMIRATES and GERMANY.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LUNA TRADING CO.PVT.LTD | NEPAL | $423.7K | 183 |
| SWASTHYAM AYURVEDA HANDEL | GERMANY | $186.8K | 18 |
| LUNA TRADING | NEPAL | $73.1K | 40 |
| KOTTAKKAL AYURVEDIC MEDICALS LLC | UNITED ARAB EMIRATES | $49.9K | 286 |
| LUNA TRADING CO.PRIVATELIMITED | NEPAL | $42.1K | 20 |
India exported $1.2M worth of Arishta through 3,193 shipments from 153 suppliers to 47 countries, serving 258 buyers globally. Kairali Exports contributes $14.5K to this total, accounting for 1.0% of India's Arishta exports.
Kairali Exports's average Arishta shipment value is $198 per consignment, based on 73 shipments totaling $14.5K.
Kairali Exports ranks #11 among 153 Indian Arishta exporters with a 1.0% market share. The top 3 exporters are DABUR INDIA LIMITED ($590.0K), GREENSHIP EXPORTS ($297.0K), SREE EXPORTS ($51.2K). Kairali Exports processed 73 shipments to 2 destination countries.
What Kairali Exports must comply with to export Arishta to its top destination countries
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | SANIYA EXPORTS IMPORTS | $21.1K | 43 | 1 | $491 |
| 10 | ASHTANGA VAIDYAM AYURVEDICS | $15.3K | 63 | 5 | $242 |
| 11 | KAIRALI EXPORTS ★ | $14.5K | 73 | 2 | $198 |
| 12 | 3PHALA AYURCENTRE PRIVATE LIMITED | $14.2K | 51 | 1 | $278 |
| 13 |
| Port | Shipments | % Share |
|---|---|---|
| COCHIN SEA (INCOK1) | 413 | 12.9% |
| COCHIN SEA | 373 | 11.7% |
| TUTICORIN SEA | 251 | 7.9% |
| TUTICORIN SEA (INTUT1) | 231 | 7.2% |
| CHENNAI SEA (INMAA1) | 181 | 5.7% |
| RAXAUL (INRXLB) | 158 | 4.9% |
| RAXAUL | 137 | 4.3% |
| Cochin Sea | 119 | 3.7% |
Kairali Exports also exports these ayurvedic & herbal products products. Each links to the detailed product page.
Kairali Exports exports 3 products worth $104.7K. Beyond Arishta, top products include Taila, Kwatha. View the complete Kairali Exports profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Arishta — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kairali Exports's Arishta exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kairali Exports
Full Company Profile →
3 products · $104.7K total trade · 1 categories
| NEPAL |
| $40.3K |
| 16 |
| SABHA GENERAL TRADING CO LLC | UNITED ARAB EMIRATES | $30.3K | 72 |
| DIPALI PHARMACEUTICALS | NEPAL | $25.2K | 38 |
| M/SKOTTAKAL AYURVEDIC MEDICALS LLC | UNITED ARAB EMIRATES | $24.5K | 134 |
| M/S. WORLD PHYSIOTHERAPY CENTRE | SAUDI ARABIA | $24.5K | 14 |
India's Arishta is purchased by 258 buyers worldwide. The top buyer is LUNA TRADING CO.PVT.LTD (NEPAL), followed by SWASTHYAM AYURVEDA HANDEL and LUNA TRADING.
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| VAIDYARATNAM OUSHADHASALA PRIVATE LIMITED |
| $12.9K |
| 74 |
| 5 |
| $175 |
Kairali Exports ranks #11 among 153 Indian Arishta exporters. Average shipment value of $198 compared to the market average of $7.9K. The closest competitors by value are SANIYA EXPORTS IMPORTS and ASHTANGA VAIDYAM AYURVEDICS.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 47+ countries, 258+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Kairali Exports.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Arishta. For current shipment-level data, contact TransData Nexus.